Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04374981Phase 2Completed
Phase 2, randomised, open-label trial of celecoxib and montelukast in osteoarthritis (OA), rheumatoid arthritis (RA), asthma and 1 more, sponsored by Damanhour University. Primary endpoints: Maximum Plasma Concentration at 12 weeks and Time to reach maximum plasma concentration at 12 weeks. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04374981.